A comparison of the effects of prostacyclin and the 15(S), 15-methyl analogs of PGE2 and PGF2-alpha on gastric parietal and nonparietal secretion.
D000818:Animals; D001101:Arbaprostil / Q000008:administration & dosage*; D002712:Chlorides / Q000378:metabolism; D015237:Dinoprost / Q000031:analogs & derivatives*; D004305:Dose-Response Relationship, Drug; D011464:Epoprostenol / Q000008:administration & dosage*; D005753:Gastric Mucosa / Q000378:metabolism*; D006859:Hydrogen / Q000378:metabolism; D008253:Macaca mulatta; D008297:Male; D011188:Potassium / Q000378:metabolism; D011453:Prostaglandins / Q000008:administration & dosage*; D011459:Prostaglandins E, Synthetic / Q000008:administration & dosage*; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage*; D012964:Sodium / Q000378:metabolism; D013268:Stimulation, Chemical
D002712:Chlorides; D011453:Prostaglandins; D011459:Prostaglandins E, Synthetic; D011461:Prostaglandins F, Synthetic; D006859:Hydrogen; D012964:Sodium; C030319:prostaglandin F2alpha 15-methyl ether; D015237:Dinoprost; D011464:Epoprostenol; D001101:Arbaprostil; D011188:Potassium